08:27 EDT Cabaletta Bio (CABA) files $240M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CABA:
- Cabaletta Bio reports Q2 EPS (73c), consensus (61c)
- Cabaletta Bio sees cash runway into 2H26
- Cabaletta Bio’s Promising Study on CABA-201 for Myasthenia Gravis: A Potential Game-Changer
- Cabaletta Bio’s RESET-SLE Study: A Promising Step in Lupus Treatment
- Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment